4//SEC Filing
Bull Horn Holdings Sponsor LLC 4
Accession 0001213900-22-068387
CIK 0001759186other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 9:30 PM ET
Size
10.2 KB
Accession
0001213900-22-068387
Insider Transaction Report
Form 4
Striar Robert
DirectorChief Executive Officer10% Owner
Transactions
- Award
Warrant
2022-10-28$1.00/sh+3,000,000$3,000,000→ 3,000,000 totalExercise: $11.50From: 2022-10-28Exp: 2027-10-28→ Common Stock (3,000,000 underlying)
Calise Chris
Director
Transactions
- Award
Warrant
2022-10-28$1.00/sh+3,000,000$3,000,000→ 3,000,000 totalExercise: $11.50From: 2022-10-28Exp: 2027-10-28→ Common Stock (3,000,000 underlying)
Bull Horn Holdings Sponsor LLC
10% Owner
Transactions
- Award
Warrant
2022-10-28$1.00/sh+3,000,000$3,000,000→ 3,000,000 totalExercise: $11.50From: 2022-10-28Exp: 2027-10-28→ Common Stock (3,000,000 underlying)
Footnotes (3)
- [F1]On October 28, 2022, Bull Horn Holdings Corp. ("Bull Horn") completed its initial business combination with Coeptis Therapeutics, Inc., a Delaware corporation ("Coeptis"), and changed its name to Coeptis Therapeutics Holdings, Inc., pursuant to that certain Agreement and Plan of Merger, dated as of April 18, 2022.
- [F2]Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of Bull Horn. The warrants could only become eligible for exercise upon consummation of Bull Horn's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of Bull Horn's initial business combination with Coeptis.
- [F3]The Sponsor is the record holder of the warrants reported herein. Christopher Calise and Robert Striar are the managing members of the Sponsor and have voting and dispositive power over the warrants held by the Sponsor. Each of Mr. Calise and Mr. Striar disclaims any beneficial ownership of the reported warrants other than to the extent of any pecuniary interest he may have therein.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001759065
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 9:30 PM ET
- Size
- 10.2 KB